Literature DB >> 26623948

Skin Penetrating Peptide as a Tool to Enhance the Permeation of Heparin through Human Epidermis.

Chiara G M Gennari1, Silvia Franzè1, Sara Pellegrino1, Emanuela Corsini2, Giulio Vistoli1, Luisa Montanari1, Paola Minghetti1, Francesco Cilurzo1.   

Abstract

This study aimed to identify a new skin penetrating peptide (SPP) able to enhance unfractionated heparin (UFH) permeation through human epidermis by screening a phage display peptide library. The effects of the synthesized heptapeptide (DRTTLTN) on human stratum corneum organization were investigated by ATR-FTIR spectroscopy and molecular dynamics simulation. The DRTTLTN penetration within the human epidermis caused both a fluidization of the stratum corneum lipids and the extension of keratins due to the increase of the contribution of α-helices. The coadministration of DRTTLTN with UFH resulted ineffective in increasing skin penetration due to UFH affinity for keratins. The conjugation of DRTTLTN to UFH by N-(3-(dimethylamino)propyl)-N'-ethylcarbodiimide hydrochloride and sodium N-hydroxysulfosuccinimide led to an increase of the flux of 24-36-fold with respect to raw UFH, depending on the adopted synthetic procedure. The new compounds showed a decrease of the antifactor Xa activity of about 4-5 times. DRTTLTN also permitted to increase the fluxes of small model molecules. In conclusion, these data support the use of SPP to enhance the skin penetration of poorly absorbed compounds even in the case of macromolecules as polysaccharides.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26623948     DOI: 10.1021/acs.biomac.5b01524

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  2 in total

Review 1.  Getting Drugs Across Biological Barriers.

Authors:  Rong Yang; Tuo Wei; Hannah Goldberg; Weiping Wang; Kathleen Cullion; Daniel S Kohane
Journal:  Adv Mater       Date:  2017-07-28       Impact factor: 30.849

2.  Enhanced transdermal delivery with less irritation by magainin pore-forming peptide with a N-lauroylsarcosine and sorbitan monolaurate mixture.

Authors:  Haerin Lee; Juhyun Park; Yeu-Chun Kim
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.